Issue 3/2023

Function, drug resistance and prognostic effect of AKR1C2 in human cancer (319 — 332)

Zhao Wang, Yue Feng, Jiayu Song, Di Sun,  Yun-Yan Zhang

DOI: 10.4149/neo_2023_230206N66

Tumor-targeted suicide gene-directed enzyme prodrug therapy mediated by extracellular vesicles (333 — 339)

Jana Jakubechova, Ursula Altanerova,  Cestmir Altaner

DOI: 10.4149/neo_2023_230328N172

NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression (340 — 349)

Guo-Fang Sun,  Hao Ding

DOI: 10.4149/neo_2023_230110N17

A new pathway for the transformation of AML in MDS: APA mechanism regulated by NUDT21 and RUNX1 (350 — 360)

Shuo Li, Fanggang Ren, Xiao-Li Liu, Hong-Yu Zhang, Zhi-Fang Xu, Daniel Muyey, Zhuanzhen Zheng, Yan-Hong Tan, Xiu-Hua Chen,  Hong-Wei Wang

DOI: 10.4149/neo_2023_230115N27

LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination (361 — 374)

Fan-Lin Zeng, Jie Lin, Xing Xie, Yuan-Kang Xie, Jian-Hong Zhang, Daofeng Xu, Xiao He, Feng Liu,  Bin-Hui Xie

DOI: 10.4149/neo_2023_230323N162

Topical application of local anesthetics to melanoma increases the efficacy of anti-PD-1 therapy (375 — 389)

Miroslav Tibensky, Filip Blasko, Peter Vargovic, Jana Jakubikova, Dana Cholujova, Jana Jakubechova,  Boris Mravec

DOI: 10.4149/neo_2023_230418N216

Effects of different-sized silver nanoparticles on morphological and functional alterations in lung cancer and non-cancer lung cells (390 — 401)

Kristina Jakic, Michal Selc, Radka Macova, Antonia Kurillova, Libor Kvitek,  Ales Panacek,  Andrea Babelova

DOI: 10.4149/neo_2023_230525N283

TRIM31 promotes the progression of oral squamous cell carcinoma through upregulating AKT phosphorylation and subsequent cellular glycolysis (402 — 415)

Sheng-Qi Sang, Yi-Jie Zhao, Meng Wang, Xiao-Qi Zhong,  Zhi-Cheng Yang,  Meng-Meng Lu

DOI: 10.4149/neo_2023_230319N155

Functional consequences of altered glycosylation of tumor-associated hypoxia biomarker carbonic anhydrase IX (416 — 429)

Magdalena Baratova, Lucia Skvarkova, Maria Bartosova, Lenka Jelenska, Miriam Zatovicova, Barbora Puzderova, Ivana Kajanova,  Lucia Csaderova, Silvia Pastorekova, Eliska Svastova

DOI: 10.4149/neo_2023_230505N246

Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis (430 — 442)

Xiao-Ling Xue, Shuai Zhao, Meng-Chang Xu, Ying Li, Wen-Fei Liu,  Hong-Zhen Qin

DOI: 10.4149/neo_2023_220904N894

Prognostic implications of the EGFR polymorphism rs763317 and clinical variables among young Chinese lung cancer population (443 — 450)

Zheng-Xing Li, Fan Wang, Zhen-Yu Sun, Chang Xu, Zi-Xiu Zou, Zong-Xu Zhao, Hai-Jian Wang, Shi-Cheng Guo, Li Jin, Qiang Li, Jiu-Cun Wang,  Fan Xia,  Xiao-Qiang Yue,  Junjie Wu

DOI: 10.4149/neo_2023_230305N115

Immunohistochemical p16 expression in the prognosis of patients with sinonasal squamous cell carcinoma (451 — 457)

Li Wang, Hua-Tao Quan, Jie Wang, Tian-Ci Tang,  Yi Li,  Xin-Mao Song

DOI: 10.4149/neo_2023_230117N34

What is the best time for postoperative radiation therapy in pN1 prostate cancer? (458 — 467)

Francesco Mistretta, Stefano Luzzago,  Giulia Marvaso, Giulia Corrao, Ilaria Sabatini, Matteo Fontana, Federico Mastroleo, Mattia Zaffaroni, Maria Vincini, Ettore Di Trapani, Gabriele Cozzi, Roberto Bianchi, Matteo Ferro, Ottavio de Cobelli, Barbara Jereczek-Fossa, Gennaro Musi

DOI: 10.4149/neo_2023_230403N182

Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma (468 — 475)

 Soňa Argalácsová, Michal Vočka, Luboš Petruželka, Miroslav Ryska †, Pavel Záruba, Zdeněk Krška, Vladimír Frýba, Jan Ulrych, Vladimír Černý, Tomáš Tůma, David Hoskovec

DOI: 10.4149/neo_2023_230409N193

Predictors of outcomes of docetaxel treatment in de novo metastatic hormone-sensitive prostate cancer: A single-center cohort study (476 — 484)

 Tomislav Omrčen, Davor Eterović, Tea Jozić, Eduard Vrdoljak

DOI: 10.4149/neo_2023_221220N1190